Biolase Technology (BLTI) Posts Q4 Loss of 4c/Share; Guides Q1 Revs Below
Tweet
Share
E-mailGet Alerts BLTI Hot Sheet
Price: $2.42 +2.54%
Financial Fact:
General and administrative: 2.78M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
General and administrative: 2.78M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Biolase Technology, Inc. (NASDAQ: BLTI) reported Q4 EPS of ($0.04), $0.02 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $13.14 million versus the consensus estimate of $13.1 million.
Sees FY2012 revenue of $11 million, versus the consensus of $13.2 million.
For earnings history and earnings-related data on Biolase Technology, Inc. (BLTI) click here.
Sees FY2012 revenue of $11 million, versus the consensus of $13.2 million.
For earnings history and earnings-related data on Biolase Technology, Inc. (BLTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
